SK pharmteco Posters

1. Generation Of A Universal AAV Packaging Cell Line For Commercial Gene Therapy Manufacturing 9/4/2025

   Uncover the benefits of this CGMP-ready, stable AAV packaging cell line with proven expertise to reduce costs, streamline manufacturing, and make life-changing gene therapies more accessible to patients in need.

2. Development Of A Serotype-Agnostic AAV Platform For Suspension Cell Culture 9/4/2025

   To evaluate performance, we compared a suspension process with an adherent iCELLis (200 m²) system, assessing upstream and downstream recovery, as well as analytics using an AAV testing platform.

3. Control Strategies And Method Development For Nitrosamines In Peptide APIs And Drug Products 11/26/2024

   Pharmaceutical scientists and engineers must advance robust, sensitive, and efficient nitrosamine detection and control methods to ensure regulatory compliance and safeguard public health in peptide-based drugs.

4. cGMP-Ready Clonal HEK293 Cell Line For AAV, Lenti-, And Adenoviral Vectors 11/7/2024

   See how this advanced SKPT-HEK293 4G9 was able to provide a robust, CGMP-ready solution for efficient viral vector production, supporting a range of AAV serotypes and CAR-T Lenti-viral vectors for scalable manufacturing.

5. Development Of A Universal, GMP-Ready, Clonal HEK293 Cell Line 9/16/2024

   When manufacturing adeno-associated virus, lenti- and adenoviral vectors, see how this HEK293 cell line is optimized for suspension culture and viral vector production, which can significantly reduce costs.